Literature DB >> 12783501

HR22C16: a potent small-molecule probe for the dynamics of cell division.

Srinivas Hotha1, Justin C Yarrow, Janet G Yang, Sarah Garrett, Kishore V Renduchintala, Thomas U Mayer, Tarun M Kapoor.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12783501     DOI: 10.1002/anie.200351173

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  17 in total

1.  Allosteric drug discrimination is coupled to mechanochemical changes in the kinesin-5 motor core.

Authors:  Elizabeth D Kim; Rebecca Buckley; Sarah Learman; Jessica Richard; Courtney Parke; David K Worthylake; Edward J Wojcik; Richard A Walker; Sunyoung Kim
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

2.  Mitotic kinesin inhibitors induce mitotic arrest and cell death in Taxol-resistant and -sensitive cancer cells.

Authors:  Adam I Marcus; Ulf Peters; Shala L Thomas; Sarah Garrett; Amelia Zelnak; Tarun M Kapoor; Paraskevi Giannakakou
Journal:  J Biol Chem       Date:  2005-01-13       Impact factor: 5.157

Review 3.  Spindle checkpoint function and cellular sensitivity to antimitotic drugs.

Authors:  Hiroshi Y Yamada; Gary J Gorbsky
Journal:  Mol Cancer Ther       Date:  2006-12       Impact factor: 6.261

4.  Docking studies on kinesin spindle protein inhibitors: an important cooperative 'minor binding pocket' which increases the binding affinity significantly.

Authors:  Cheng Jiang; Yadong Chen; Xiaojian Wang; Qidong You
Journal:  J Mol Model       Date:  2007-06-23       Impact factor: 1.810

5.  Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein.

Authors:  Tanja Peters; Heike Lindenmaier; Walter E Haefeli; Johanna Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-12-20       Impact factor: 3.000

6.  Dimethylenastron suppresses human pancreatic cancer cell migration and invasion in vitro via allosteric inhibition of mitotic kinesin Eg5.

Authors:  Xiao-dong Sun; Xing-juan Shi; Xiao-ou Sun; You-guang Luo; Xiao-jing Wu; Chang-fu Yao; Hai-yang Yu; Deng-wen Li; Min Liu; Jun Zhou
Journal:  Acta Pharmacol Sin       Date:  2011-10-10       Impact factor: 6.150

Review 7.  Kinesins and cancer.

Authors:  Oliver Rath; Frank Kozielski
Journal:  Nat Rev Cancer       Date:  2012-07-24       Impact factor: 60.716

Review 8.  Kinesin-5: cross-bridging mechanism to targeted clinical therapy.

Authors:  Edward J Wojcik; Rebecca S Buckley; Jessica Richard; Liqiong Liu; Thomas M Huckaba; Sunyoung Kim
Journal:  Gene       Date:  2013-08-14       Impact factor: 3.688

9.  NSC 622124 inhibits human Eg5 and other kinesins via interaction with the conserved microtubule-binding site.

Authors:  Sarah S Learman; Catherine D Kim; Nathaniel S Stevens; Sunyoung Kim; Edward J Wojcik; Richard A Walker
Journal:  Biochemistry       Date:  2009-03-03       Impact factor: 3.162

10.  Single-molecule inhibition of human kinesin by adociasulfate-13 and -14 from the sponge Cladocroce aculeata.

Authors:  Thomas E Smith; Weili Hong; Malcolm M Zachariah; Mary Kay Harper; Teatulohi K Matainaho; Ryan M Van Wagoner; Chris M Ireland; Michael Vershinin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.